{"name":"Friedemann Paul","slug":"friedemann-paul","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5YWGRERU45VUxZMnhnMWRCdEJyNXE5OVdDQXNiRWQ5LWtXR2hMZ05wdndsNmdGdVRlWjI4aVZDZE5paVdWU1M5STNXMHFzbVpIajhCbndyX2FJRTFDV1B3dG1JUlQ3clptUmFpbEdRTk8yUTREXzJFYW9JWQ?oc=5","date":"2025-01-13","type":"trial","source":"medRxiv","summary":"The Presence of a Paramagnetic Phase Rim is Linked to Lesion Age in Multiple Sclerosis - medRxiv","headline":"The Presence of a Paramagnetic Phase Rim is Linked to Lesion Age in Multiple Sclerosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE9WSGowS0RjWFE3U3Q4OTl2a29pQ1VKODVWLXlBZHhVb1h5UXcwajlmWjZSQ1JmdDBWdGRBVVdhb0JXNk5XMnJPZG9ZbVM4WjJNZ3ROUG9KYjRkOVk?oc=5","date":"2023-07-06","type":"pipeline","source":"EurekAlert!","summary":"Ten million euros for improved treatment of multiple sclerosis - EurekAlert!","headline":"Ten million euros for improved treatment of multiple sclerosis - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNcVEwSWxWRkFleFo0dWpNX2N2ZUJFSkZFVmFFRTJ0TERFcURSOFNHQ2thSjY2cTNram1iT1QyeHp6d2h0NWlsS2ppSUFmOXc4VDI2eUJnaGh1X3duUTkzTDhTSTV6U0NKQ2hVUExVU2QyNWdfbGk2UFNQenh3YnNCYXo4eHZwUQ?oc=5","date":"2023-07-05","type":"trial","source":"pharmaphorum","summary":"Positive new phase 3 MRI data from UPLIZNA trial for NMOSD - pharmaphorum","headline":"Positive new phase 3 MRI data from UPLIZNA trial for NMOSD","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}